Akebia Therapeutics, Inc. (AKBA)
0.919
-0.01
(-1.46%)
USD |
NASDAQ |
Sep 24, 16:00
0.9151
0.00 (0.00%)
After-Hours: 19:59
Akebia Therapeutics Gross Profit (Annual) : 195.46M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 195.46M |
| December 31, 2024 | 91.34M |
| December 31, 2023 | 118.89M |
| December 31, 2022 | 205.26M |
| December 31, 2021 | 59.05M |
| December 31, 2020 | 112.85M |
| December 31, 2019 | 189.65M |
| December 31, 2018 | 199.08M |
| Date | Value |
|---|---|
| December 31, 2017 | 180.61M |
| December 31, 2016 | 0.00 |
| December 31, 2015 | -0.096M |
| December 31, 2014 | -0.049M |
| December 31, 2013 | -0.0013M |
| December 31, 2012 | 0.00 |
| December 31, 2011 | -0.0392M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Emergent BioSolutions, Inc. | 350.60M |
| Exelixis, Inc. | 2.236B |
| ADMA Biologics, Inc. | 292.62M |
| Arcutis Biotherapeutics, Inc. | 339.38M |
| Relay Therapeutics, Inc. | 11.80M |